Potential Impact of Treatment with Inotuzumab Ozogamicin on Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia

被引：2
|
作者：
Ceolin, Valeria [1 ,2 ]
Brivio, Erica [2 ,3 ]
Rheingold, Susan R. [4 ]
Leahy, Allison Barz [5 ]
Vormoor, Britta Julia [2 ]
O'Brien, Maureen M. [6 ]
Rubinstein, Jeremy [7 ]
Kalwak, Krzysztof [8 ]
De Moerloose, Barbara [9 ]
Jacoby, Elad [10 ,11 ]
Bader, Peter [12 ]
Fuster, Jose L. [13 ]
Locatelli, Franco [14 ]
Hoogerbrugge, Peter [2 ]
Calkoen, Friso [2 ]
Zwaan, Christian M. [2 ,3 ]
机构：
[1] Univ Turin, Regina Margherita Childrens Hosp, Dept Pediat Oncol Hematol, Turin, Italy
[2] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[3] Erasmus Univ, MC Sophia Childrens Hosp, Rotterdam, Netherlands
[4] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Pediat Oncol, Philadelphia, PA USA
[5] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA USA
[6] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA
[7] Univ Cincinnati, Canc & Blood Dis Inst, Cincinnati Childrens Hosp, Sch Med,Med Ctr, Cincinnati, OH USA
[8] Wroclaw Med Univ, Dept Pediat Hematol Oncol & Bone Marrow Transplan, Wroclaw, Poland
[9] Ghent Univ Hosp, Dept Pediat Oncol Hematol & Stem Cell Transplanta, Ghent, Belgium
[10] Edmond & Lily Safra Childrens Hosp, Div Pediat Hematol Oncol & BMT, Sheba Med Ctr, Tel Aviv, Israel
[11] Sackler Fac Med, Tel Aviv, Israel
[12] Goethe Univ, Univ Hosp Frankfurt, Dept Pediat Oncol Hematol, Clin Children & Youth Med, Frankfurt, Germany
[13] Hosp Valdecilla, Dept Hematol, Pediat Hematol Unit, Santander, Spain
[14] Sapienza Univ Rome, Bambino Gesu Childrens Hosp, Dept Hematol Oncol & Cell & Gene Therapy, Rome, Italy
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-146556
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3824
引用
收藏
页码：3824 / +
页数：5
相关论文
共 50 条
  • [31] BUDGET IMPACT ANALYSIS OF INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF ADULTS WITH RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN THE NETHERLANDS
    van Oostrum, I
    De Lameillieure, K.
    Russell-Smith, T. A.
    VALUE IN HEALTH, 2020, 23 : S444 - S444
  • [32] CASES OF RELAPSED AND REFRACTORY B CELL PRECURSOR-ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY
    Kurita, Daisuke
    Yamanishi, Jun
    Osuna, Mitsumasa
    Ikeda, Junji
    Tsujimoto, Shinichi
    Takeuchi, Masanobu
    Tanoshima, Reo
    Shiba, Norio
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S104 - S104
  • [33] NELARABINE IN CHILDREN WITH REFRACTORY AND RELAPSED T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Myakova, N.
    Diakonova, Y.
    Bydanov, O.
    Ponomareva, N.
    Fechina, L.
    Boychenko, E.
    Karachunsky, A.
    Shamardina, A.
    HAEMATOLOGICA, 2015, 100 : 349 - 349
  • [34] BUDGET IMPACT ANALYSIS OF INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF ADULTS WITH RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN BULGARIA
    Djambazov, S.
    Slavchev, G.
    Encheva-Malinova, M.
    Pavlova, Y.
    Varbanova, V.
    Velchev, M.
    Vekov, T.
    VALUE IN HEALTH, 2018, 21 : S26 - S26
  • [35] PHARMACOECONOMIC PERSPECTIVES ON THE USE OF INOTUZUMAB OZOGAMICIN IN THE TREATMENT OF RELAPSED OR REFRACTORY FORMS OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Kolbin, A.
    Velum, I
    Balykina, Y.
    Proskurin, M.
    VALUE IN HEALTH, 2019, 22 : S501 - S501
  • [36] The Evolution of Chimeric Antigen Receptor T-Cell Therapy in Children, Adolescents and Young Adults with Acute Lymphoblastic Leukemia
    Ragoonanan, Dristhi
    Sheikh, Irtiza N.
    Gupta, Sumit
    Khazal, Sajad J.
    Tewari, Priti
    Petropoulos, Demetrios
    Li, Shulin
    Mahadeo, Kris M.
    BIOMEDICINES, 2022, 10 (09)
  • [37] Infections in children following chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia
    Diamond, Yonatan
    Gilsenan, Maddie
    Wang, Stacie Shiqi
    Hanna, Diane
    Conyers, Rachel
    Cole, Theresa
    Hughes, David
    Fleming, Jacqueline
    Meyran, Deborah
    Toro, Claudia
    Malalasekera, Vajiranee
    Khaw, Seong Lin
    Haeusler, Gabrielle M.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (06)
  • [38] Analysis of 60 patients with relapsed or refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma treated with CD7-targeted chimeric antigen receptor-T cell therapy
    Zhang, Xian
    Yang, Junfang
    Li, Jingjing
    Qiu, Liyuan
    Zhang, Jianping
    Lu, Yue
    Zhao, Yan-li
    Jin, David
    Li, Jianqiang
    Lu, Peihua
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (12) : 1898 - 1908
  • [39] Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
    Ding, Jing
    Li, Deyu
    Liu, Xingchen
    Hei, Hu
    Sun, Baoxi
    Zhou, Dongmin
    Zhou, Keshu
    Song, Yongping
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022, 11 (01)
  • [40] Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
    Jing Ding
    Deyu Li
    Xingchen Liu
    Hu Hei
    Baoxi Sun
    Dongmin Zhou
    Keshu Zhou
    Yongping Song
    Experimental Hematology & Oncology, 11
12345